Mita Patel, M.D.
Internal Medicine Physician in Marina Del Rey, California.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 172,737 in Internal Medicine Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Mita Patel, M.D. filed 772 Medicare Part D claims in 2023 as an Internal Medicine Physician in Marina Del Rey, California, prescribing 79% generic.
- 772
- Part D claims, 2023
- 79%
- generic prescribing
- Likely
- board-certified (heuristic)
- ≥71st
- pct by Part D claim volume (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
CMS NPPES provider registry desk
NPI 1609032986 · Internal Medicine Physician
NPI-10 · ENUM-MID · TAX-MEGA · RX-LIGHT · BOOK-MID · PHOTO-ENUM
- NPI-10 1609032986
- ENUM-MID 2008
- TAX-MEGA 173K Internal Medicine
- RX-LIGHT 772
- BOOK-MID 20,046 in California
- PHOTO-ENUM Anju Paul · 2008
Mita Patel, M.D.'s Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023, across all CMS prescribers nationally
772 ≥ 71st percentile 71% of 1,370,886 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2023
Mita Patel, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Mita Patel, M.D.?
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in California
How Internal Medicine Physician compares to other specialties among California providers
Internal Medicine Physician ranks #10 among California's specialties (2.1% of in-state providers)
Each bar is a specialty's share of the California provider total, by primary NUCC taxonomy. The highlighted bar is Internal Medicine Physician; the long tail of smaller specialties is omitted for legibility.
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Internal Medicine Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1609032986 |
|---|---|
| Specialty | Internal Medicine Physician |
| Credentials | M.D. |
| Gender | Female |
| NPI Issued | 08/06/2008 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Mita Patel, M.D.'s current license status, disciplinary history, and board certifications with the Medical Board of California in California before relying on this page for a clinical or care decision.
How we sourced this profile
Profile fields combine the CMS NPPES monthly snapshot (provider directory, taxonomy, and address) with calendar-year 2023 Medicare Part D and MIPS public-use files when records are present. NPI 1609032986 is the unique 10-digit identifier CMS uses to link Patel across every Medicare, Medicaid, and HIPAA-covered transaction. Read full methodology →
Hospital and facility affiliations
Facilities where Mita Patel, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Mita Patel, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$146
Largest payer
Kestra Medical Technology Services, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - California MBC 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 - they are NOT specific to Mita Patel, M.D.. To verify Mita Patel, M.D.'s current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Typical
21% brand-name claims vs 79% generic, on 772 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 2,112
- Total Day Supply
- 63,174
- Brand vs Generic
- 21% brand / 79% generic
- Brand Drug Cost
- $205K
- Generic Drug Cost
- $12K
Patient Demographics
- Average Patient Age
- 77.1 years
- Avg HCC Risk Score
- 1.69
- Gender Split
- 48% female / 52% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Mita Patel, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Eliquis
Eliquis
99 claims
- Metoprolol Succinate
Metoprolol Succinate
95 claims
- Atorvastatin Calcium
Atorvastatin Calcium
84 claims
- Hydralazine Hcl
Hydralazine Hcl
68 claims
- Amlodipine Besylate
Amlodipine Besylate
49 claims
- Metoprolol Tartrate
Metoprolol Tartrate
45 claims
- Carvedilol
Carvedilol
44 claims
- Lisinopril 36
Lisinopril
36 claims
| Drug | Claims |
|---|---|
| Eliquis Apixaban | 99 |
| Metoprolol Succinate | 95 |
| Atorvastatin Calcium | 84 |
| Hydralazine Hcl | 68 |
| Amlodipine Besylate | 49 |
| Metoprolol Tartrate | 45 |
| Carvedilol | 44 |
| Lisinopril | 36 |
| Entresto Sacubitril/Valsartan | 26 |
| Furosemide | 25 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Internal Medicine Physician Overview
How Mita Patel, M.D. fits within the Internal Medicine Physician landscape nationally.
Mita Patel, M.D.'s 772 claims are below the specialty average of 2,716.
Nationwide Internal Medicine Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Patel, both outside California so the neighborhoods are not geographic containment.
Same NPPES enumeration year (2008)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Internal Medicine Physician Providers in California
Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as Patel.
One of 20,046 Internal Medicine Physician providers enrolled in California, 5 are shown here.
Compare Internal Medicine Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Mita Patel, M.D.'s specialty? ▼
How much does Mita Patel, M.D. prescribe under Medicare Part D? ▼
Where is Mita Patel, M.D. located? ▼
What is Mita Patel, M.D.'s NPI number? ▼
Does Mita Patel, M.D. prescribe more brand-name or generic drugs? ▼
How many Internal Medicine Physician providers are there in the US? ▼
What drugs does Mita Patel, M.D. prescribe most often? ▼
Does Mita Patel, M.D. accept Medicare? ▼
How can I verify Mita Patel, M.D.'s credentials? ▼
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.
Published by
PlainDoctor
Independent public-data reference that compiles, verifies, and contextualizes official datasets. We do not accept compensation from entities we cover, and every dataset cites its originating public source.